In Vitro Inhibitory Effects of Pulvinic Acid Derivatives Isolated from Chinese Edible Mushrooms, Boletus calopus and Suillus bovinus, on Cytochrome P450 Activity

被引:18
作者
Huang, Yu-Ting [1 ]
Onose, Jun-ichi [1 ]
Abe, Naoki [1 ]
Yoshikawa, Kunie [1 ]
机构
[1] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci, Setagaya Ku, Tokyo 1568502, Japan
关键词
atromentic acid; variegatic acid; xerocomic acid; cytochrome P450 (CYP) inhibition; ferryl heme reductant; GRAPEFRUIT JUICE; 3A4; ENZYMES; CYP3A; NIFEDIPINE; COMPONENTS; PIGMENTS; FUNGI;
D O I
10.1271/bbb.80759
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increasing attention has been focused on food-drug interactions. We have investigated the inhibitory effect of Chinese edible mushrooms, Boletus calopus and Suillus bovinus, oil cytochrome P450 (CYP) 1A2, 2C9, 2D6, and 3A4, the main drug-metabolizing enzymes. Three pulvinic acid derivatives, atromentic acid (1), variegatic acid (12), and xerocomic acid (3), isolated from Boletus calopus and Suillus bovinus, revealed nonspecific inhibitory effects on all four CYPs. Using these compounds, the maximum IC50 values obtained with CYP3A4 in vitro were atromentic acid (1), 65.1 +/- 3.9 mu M; variegatic acid (2), 2.2 +/- 0.1 mu M; and xerocomic acid (3), 2.4 +/- 0.1 mu M. Variegatic acid (2) and xerocomic acid (3) were effective inhibitors, comparable to cimetidine, dicoumarol, erythromycin, safrole, and uniconazole. Variegatic acid (2) and xerocomic acid (3) efficiently reduced ferryl myoglobin in CYPs. Reduction of ferryl heme to ferric heme is likely the mechanism of the nonspecific inhibitory effects of these compounds on CYPs.
引用
收藏
页码:855 / 860
页数:6
相关论文
共 26 条
[1]   Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors [J].
Afzelius, L ;
Zamora, I ;
Masimirembwa, CM ;
Karlén, A ;
Andersson, TB ;
Mecucci, S ;
Baroni, M ;
Cruciani, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (04) :907-914
[2]   Synthesis of natural pulvinic acids based on a '[3+2] cyclization-Suzuki cross-coupling' strategy [J].
Ahmed, Z ;
Langer, P .
TETRAHEDRON, 2005, 61 (08) :2055-2063
[3]   GRAPEFRUIT JUICE AND DRUGS - HOW SIGNIFICANT IS THE INTERACTION [J].
BAILEY, DG ;
ARNOLD, JMO ;
SPENCE, JD .
CLINICAL PHARMACOKINETICS, 1994, 26 (02) :91-98
[4]   INTERACTION OF CITRUS JUICES WITH FELODIPINE AND NIFEDIPINE [J].
BAILEY, DG ;
SPENCE, JD ;
MUNOZ, C ;
ARNOLD, JMO .
LANCET, 1991, 337 (8736) :268-269
[5]   Grapefruit juice-drug interactions [J].
Bailey, DG ;
Malcolm, J ;
Arnold, O ;
Spence, JD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (02) :101-110
[6]   Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development [J].
Bruno, Robert D. ;
Njar, Vincent C. O. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (15) :5047-5060
[7]   Simple method for reversed-phase high-performance liquid chromatographic analysis of fungal pigments in fruit-bodies of Boletales (Fungi) [J].
Davoli, P ;
Weber, RWS .
JOURNAL OF CHROMATOGRAPHY A, 2002, 964 (1-2) :129-135
[8]   Hydroxylation of camphor by-reduced oxy-cytochrome P450cam: Mechanistic implications of EPR and ENDOR studies of catalytic intermediates in native and mutant enzymes [J].
Davydov, R ;
Makris, TM ;
Kofman, V ;
Werst, DE ;
Sligar, SG ;
Hoffman, BM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (07) :1403-1415
[9]  
Edwards DJ, 1996, DRUG METAB DISPOS, V24, P1287
[10]  
Ekins S, 1999, J PHARMACOL EXP THER, V290, P429